S. Vignati
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- RNA modifications and cancer 3
- TGF-β signaling in diseases 2
- Oncology 10
- Cancer-related Molecular Pathways 4
- HER2/EGFR in Cancer Research 2
- Co-authors
- Gabriella Fontanini (18 shared papers)Generoso Bevilacqua (11 shared papers)A Mussi (12 shared papers)Marco Lucchi (10 shared papers)Fulvio Basolo (8 shared papers)Carlo Alberto Angeletti (5 shared papers)S Chinè (7 shared papers)Vanesa L. Silvestri (4 shared papers)
- Journals
- British Journal of Cancer (3 papers)Lung Cancer (3 papers)European Journal of Cancer (3 papers)International Journal of Oncology (2 papers)Veterinary Research Communications (1 paper)
- Partner nations
- ItalyUnited KingdomBelgium
In The Last Decade
S. Vignati
22 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 79
- Oncology 793
- Cancer Research 388
- Pulmonary and Respiratory Medicine 569
- Hepatology 113
- Molecular Biology 879
Countries citing papers authored by S. Vignati
This map shows the geographic impact of S. Vignati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vignati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vignati more than expected).
Fields of papers citing papers by S. Vignati
This network shows the impact of papers produced by S. Vignati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vignati. The network helps show where S. Vignati may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Vignati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. | 1997 | 266 |
| 2 | Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. | 1998 | 262 |
| 3 | 1997 | 241 | |
| 4 | 1995 | 172 | |
| 5 | 1995 | 110 | |
| 6 | 1997 | 105 | |
| 7 | 1998 | 84 | |
| 8 | 1996 | 76 | |
| 9 | Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma. | 1996 | 45 |
| 10 | 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. | 1997 | 37 |
| 11 | Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. | 1992 | 37 |
| 12 | 1994 | 25 | |
| 13 | 1994 | 25 | |
| 14 | Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. | 1996 | 24 |
| 15 | 2010 | 14 | |
| 16 | 1997 | 11 | |
| 17 | 2002 | 8 | |
| 18 | [Post-operative examination of 2930 thyroid glands: observations on primary carcinoma. Incidental carcinoma and the preoperative diagnostic assessment of thyroidectomy for cancer]. | 1994 | 6 |
| 19 | 1994 | 3 | |
| 20 | 1994 | 2 |
About S. Vignati
S. Vignati is a scholar working on Molecular Biology, Oncology, Cancer Research, Hepatology and Endocrinology, Diabetes and Metabolism, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Lipids, and Metabolism (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), TGF-β signaling in diseases (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (793 citations), Cancer Research (388 citations), Pulmonary and Respiratory Medicine (569 citations), Hepatology (113 citations) and Molecular Biology (879 citations). S. Vignati has collaborated with scholars based in Italy, United Kingdom and Belgium. Frequent co-authors include Gabriella Fontanini, Generoso Bevilacqua, A Mussi, Marco Lucchi, Fulvio Basolo, Carlo Alberto Angeletti, S Chinè, Vanesa L. Silvestri, C. A. Angeletti and D Bigini. Their work appears in journals such as British Journal of Cancer, Lung Cancer, European Journal of Cancer, International Journal of Oncology and Veterinary Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.